Scott Rocklage, Ph.D.; a Managing Partner of 5AM Ventures, has an experience of over 30 years in healthcare management with strategic leadership commitment that resulted in the approval of three New Drug Applications in the United States. This has enabled several drug candidates to enter into clinical trials. Dr. Rocklage joined 5AM Ventures as a Venture Partner in 2003 and later became a Managing Partner in 2004.
Dr. Rocklage has served as the Chief Executive Officer (CEO) and Chairman of Cubist Pharmaceuticals; a biopharmaceutical firm that focuses on the development, research, and commercialization of products that address vital needs in the care environment and as CEO and President of Nycomed Salutar; a biotechnology company. He also held various research and development (R&D) positions at Catalytica and Salutar. Currently, Dr. Rocklage serves as the Board Chairman of Kinestral, Rennovia, and Cidara. He also serves on the Boards of Pulmatrix and Epirus.
Formerly the Executive Chairman of Miikana that was acquired by EntreMed, Semprus; acquired by Teleflex, and Ilypsa; acquired by Amgen, Dr. Rocklage earned his Bachelor of Science degree in Chemistry from the University of California, Berkley. He holds a Ph.D. in Chemistry from the Institute of Technology Massachusetts where he researched from the Richard Schrock Laboratory; a 2005 Nobel Winning Chemistry laboratory. Dr. Rocklage is the co-inventor or an inventor on more than 30 patents in the United States and over 100 publications that have been peer-reviewed. Based in Boston, Dr. Rocklage has an extensive scientific background, leadership track record, and healthcare management experience. Click here to know more.
5AM Ventures is a leading venture capital company focused on establishing next-generation life science firms that are capable of delivering exceptional returns to their investors. They support enterprises that are aiming at providing solutions to pressing health care concerns through cutting-edge successes in science and medicine. Moreover, their pioneering companies spearhead the best approaches to diagnose, treat, and prevent various medical conditions.
5AM Venture professionals have substantial medical, scientific, operational, finance, and legal expertise. Their complementary backgrounds also offer them a unique way of finding and shaping life science firms. The venture is always directly involved in setting solid strategy, business development, fundraising, and management recruitment. Apart from taking on short-term operational roles, 5AM professionals contribute as board members in various healthcare organizations.